| Stage | DCH | % of rev | VGNT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.0B | 100.00% | $2.5B | 100.00% | DCH ×1.21 |
| Gross profit | $338M | 11.44% | $330M | 13.47% | VGNT +2.0pp |
| Operating income | $100M | 3.37% | $185M | 7.55% | VGNT +4.2pp |
| Pre-tax income | $18M | 0.60% | $147M | 6.00% | VGNT +5.4pp |
| Net income | $2M | 0.05% | $112M | 4.57% | VGNT +4.5pp |
| Stage | DCH | VGNT | Gap · A − B |
|---|---|---|---|
| Revenue | $3.0B100.00% | $2.5B100.00% | DCH ×1.21 |
| Gross profit | 11.44%$338M | 13.47%$330M | VGNT +2.0pp |
| Operating income | 3.37%$100M | 7.55%$185M | VGNT +4.2pp |
| Pre-tax income | 0.60%$18M | 6.00%$147M | VGNT +5.4pp |
| Net income |
| 0.05%$2M |
| 4.57%$112M |
| VGNT +4.5pp |
No disclosed counterparties: VGNT.
None